The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), and the National Heart, Lung, and Blood Institute (NHLBI).
Donor Name: National Institutes of Health (NIH)
Country: U.S.
Territory: American Samoa, Guam, Northern Mariana Islands, Puerto Rico, and U.S. Virgin Islands
State: All States
Type of Grant: Grant
Deadline (mm/dd/yyyy): 02/05/2022
Size of the Grant: $2,150,000
Grant Duration: 5 years
Details:
Investigator-initiated research project grant applications (R01s) in specific areas of basic and early translational hematology research are invited to this program that supports growth in the nonmalignant hematology research domain.
The overall objectives of the SHINE program are to catalyze discoveries in basic molecular and cellular biology that provide new insights into the pathogenesis, prevention, detection, and potential treatment of nonmalignant hematologic diseases; to attract new investigators into basic and translational hematology research; to promote productive interdisciplinary research collaborations; and to reinforce a flexible, proactive role for the NIA, NHLBI, and NIDDK to support timely, high impact, leading-edge research by the hematology research community.
The focus of research supported by the SHINE program will vary. In general, the knowledge gaps and research opportunities addressed by the SHINE program will include those that are defined and highlighted by workshops and other public meetings. These workshops are open to the public and interested researchers are invited to attend and participate.
Current research objectives that will continue to be supported by the “Stimulating Hematology Investigation: New Endeavors (SHINE)” program are:
- Role of Macrophages in Blood Cell Development.
- Effects of Aging on Hematopoiesis.
- Metabolic Modulators of Hematopoiesis.
- Remodeling the Hematopoietic Stem Cell Niche.
- Biology of Erythrocyte Maturation.
- Hematopoietic Response to Stress.
Funding Information
- NIH intends to fund an estimated 2-9 awards beyond its regular/standard R01 funding policies, corresponding to a total of $2,150,000 in FY2022. Future year amounts will depend on annual appropriations.
- The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Eligible Organizations
- Higher Education Institutions
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
- Nonprofits Other Than Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- For-Profit Organizations
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- Local Governments
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Federal Governments
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Other
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
For more information, visit Grants.gov.
